EBS News and Press, Emergent Biosolutions Inc. From 08/27/25

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences: Wells Fargo 20 th Annual Healthcare Conference Se...

2025-08-12 12:46:31 ET ... Read the full article on Seeking Alpha For further details see: Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

2025-08-07 19:31:54 ET Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Conference Call August 06, 2025, 5:00 PM ET Company Participants Joseph C. Papa - CEO, President & Director Richard S. Lindahl - Executive VP, CFO & Treasurer Conference Call Parti...

A look at the top 10 most actives in the United States CIMG Inc. (IMG) rose 113.5% to $0.427 on volume of 701,755,593 shares Incannex Healthcare Inc. (IXHL) rose 34.1% to $0.4625 on volume of 275,339,019 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.6% to $7.66 on volume ...

2025-08-06 16:24:53 ET More on Emergent Biosolutions Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful Emergent Biosolutions Q2 2025 Earnings Preview Emergent BioSolutions signs contract modification award for CNJ-016 Seeking A...

Second Quarter 2025 Total Revenues of $140.9 million, above Q2 guidance by $21 million Second Quarter 2025 Net Loss of $12.0 million and Net Loss Margin of (9)%, an improvement of 96% and 10,200 bps, respectively, versus prior year Second Quarter 2025 Gross Margin % of 36% and Adjusted Gr...

2025-08-06 10:00:00 ET Major earnings expected after the bell on Wednesday include: Realty Income Corporation ( O ) Energy Transfer LP ( ET ) Occidental Petroleum Corporation ( OXY ) Airbnb ( ABNB ) DraftKings ( DKNG ) Read the full article ...

Sera Prognostics Inc. (SERA) is expected to report $-0.21 for Q2 2025 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.51 for Q2 2025 Context Therapeutics Inc. (CNTX) is expected to report $-0.06 for Q2 2025 Genco Shipping & Trading ...

Emergent BioSolutions Inc. (EBS) is expected to report $-0.26 for Q2 2025

GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the publication of a comprehensive review article, "Brincidofovir in the Era of Mpox," in the peer-reviewed journal Expert Review of Anti-infective Therapy . 1 This publication incl...